Analysis of the evolution to defined connective tissue diseases of patients with "early unidifferentiated connective tissue diseases (UCTD)";Evoluzione verso connettiviti definite in una popolazione di pazienti affetti da "early undifferentiated connective tissue diseases (UCTD)"

Reumatismo

Volumn 60, Issue 1, 2008, Pages 35-40

  Mosca, Marta ^a   Tani, C ^a   Neri, C ^a   Della Rossa, A ^a   Baldini, C ^a   Talarico, R ^a   Carli, L ^a   Bombardieri, S ^a  

^a UNIVERSITY OF PISA   (Italy)

Author keywords

Anti cardiolipin antibodies; Classificative critieria; Defined connective tissue diseases; Undifferentiated connective tissue diseases

Indexed keywords

CARDIOLIPIN ANTIBODY; RIBONUCLEOPROTEIN ANTIBODY; RO ANTIBODY;

ANTIBODY DETECTION; ANTIBODY SPECIFICITY; ARTICLE; AUTOIMMUNE DISEASE; CLINICAL FEATURE; COHORT ANALYSIS; CONNECTIVE TISSUE DISEASE; CONTROLLED STUDY; DISEASE CLASSIFICATION; DISEASE DURATION; FEMALE; FOLLOW UP; HUMAN; MAJOR CLINICAL STUDY; MALE; RHEUMATOID ARTHRITIS; SJOEGREN SYNDROME; SYSTEMIC LUPUS ERYTHEMATOSUS; SYSTEMIC SCLEROSIS; UNDIFFERENTIATED CONNECTIVE TISSUE DISEASE;

ADOLESCENT; ADULT; AGED; CHILD; COHORT STUDIES; CONNECTIVE TISSUE DISEASES; DISEASE PROGRESSION; FEMALE; HUMANS; MALE; MIDDLE AGED; YOUNG ADULT;

EID: 57149124528     PISSN: 00487449     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (38)

1. Moutsopoulos HM, Talal N. Viewpoint. Connective tissue diseases: One disease or many? Lupus 1994; 3: 5-10.
2. LeRoy EC, Maricq HR, Kahaleh MB. Undifferentiated connective tissue syndromes. Arthritis Rheum 1980; 23: 341-3.
3. Ganczarczyk L, Urowitz MB, Gladman DD. Latent lupus. J Rheumatol 1989; 16: 475-8.
4. Greer JM, Panush RS. Incomplete lupus erythematosus. Arch Intern Med 1989; 149: 2473-6.
5. Alarcón GS, Williams GV, Singer JZ, Steen VD, Clegg DO, Paulus HE, et al. Early undifferentiated connective tissue disease. I. Early clinical manifestations in a large cohort of patients with undifferentiated connective tissue diseases compared with cohorts of well-established connective tissue disease. J Rheumatol 1991; 18: 1332-9.
6. Clegg DO, Williams JH, Singer JZ, Steen VD, Schlegel S, Ziminski C, et al. Early undifferentiated connective tissue disease. II. The frequency of circulating antinuclear antibodies in patients with early rheumatic diseases. J Rheumatol 1991; 18: 1340-3.
7. Mosca M, Tavoni A, Neri R, Bencivelli W, Bombardieri S. Undifferentiated connective tissue diseases: The clinical and serological profiles in 91 patients followed for at least 1 year. Lupus 1998; 7: 95-100.
8. Danieli MG, Fraticelli P, Franceschini F, Cattaneo R, Farsi A, Passaleva A, et al. Five-year follow-up of 165 Italian patients with undifferentiated connective tissue diseases. Clin Exp Rheumatol 1999; 17: 585-91.
9. Dijkstra S, Nieuwenhuys EJ, Swaak AJ. The prognosis and outcome of patients referred to an outpatient clinic for rheumatic diseases characterized by the presence of antinuclear antibodies (ANA). Scand J Rheumatol 1999; 28: 33-7.
10. Williams HJ, Alarcón GS, Joks R, Steen VD, Bulpitt K, Clegg DO et al. Early undifferentiated tissue disease. VI. An inception cohort after 10 years: Disease remissions and changes in diagnoses in well established and undifferentiated CTD. J Rheumatol 1999; 26: 816-25.
11. Vila LM, Mayor AM, Valentin AH, Garcia- Soberal M, Vila S. Clinical outcome and predictors of disease evolution in patients with incomplete lupus erythematosus. Lupus 2000; 9: 110-5.
12. Swaak AJ, van de Brink H, Smeenk RJ, Manger K, Kalden JR, Tosi S, et al. Incomplete lupus erythematosus: Results of a multicenter study under the supervision of the EULAR Standing Committee on International Clinical Studies Including Therapeutic Trials (ESCISIT). Rheumatology 2001; 40: 89-94.
13. Cavazzana I, Franceschini F, Belfiore N, Quinzanini M, Caporali R, Calzavara-Pinton P, et al. Undifferentiated connective tissue disease with antibodies to Ro/SSA: Clinical features and follow up of 148 patients. Clin Exp Rheumatol 2001; 19: 403-9.
14. Mosca M, Neri R, Bencivelli W, Tavoni A, Bombardieri S. Undifferentiated connective tissue disease: Analysis of 83 patients with a minimum follow up of 5 years. J Rheumatol 2002; 29: 2345-9.
15. Bodolay E, Csiki Z, Szekanecz Z, Ben T, Kiss E, Zeher M, et al. Five-year follow-up of 665 Hungarian patients with undifferentiated connective tissue disease (UCTD). Clin Exp Rheumatol 2003; 21: 313-20.
16. Mosca M, Neri R, Strigini F, Carmignani A, Totti D, Tavoni A, Bombardieri S. Pregnancy outcome in patients with undifferentiated connective tissue disease: A preliminary study on 25 pregnancies. Lupus 2002; 11: 304-7.
17. Tan EM, Cohen AS, Fries JF, Masi AT, McShane DJ, Rothfield NF, et al. The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 1982; 25: 1271-7.
18. Hochberg MC. Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 1997; 40: 1725.
19. Sharp GC. Diagnostic criteria for classification of MCTD. In: Kasukawa R and Sharp GC (Editors). MCTD and Anti-Nuclear Antibodies. Amsterdam, Elsevier 1987: 23-32.
20. Bohan A, Peter JB. Polymyositis and dermatomyositis. Part I. N Engl J Med 1975; 292: 344-7.
21. Bohan A, Peter JB. Polymyositis and dermatomyositis. Part II. N Engl J Med 1975; 292: 403-7.
22. Arnett FC, Edworthy SM, Bloch DA, McShane DJ, Fries JF, Cooper NS, et al. The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum 1988; 31: 315-24.
23. Vitali C, Bombardieri S, Moutsopoulos HM, Balestrieri G, Bencivelli W, Bernstein RM, et al. Preliminary criteria for the classification of Sjögren's syndrome. Results of a prospective concerted action supported by the European Community. Arthritis Rheum 1993; 36: 340-7.
24. Miyakis S, Lockshin MD, Atsumi T, Branch DW, Brey RL, Cervera R, et al. International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS). J. Thromb. Haemost. 2006; 4: 295-306.
25. Subcommitte for Scleroderma Criteria of the American Rheumatism Association Diagnostic and Therapeutic Criterion Committee: Preliminary criteria for the classification of systemic sclerosis (scleroderma). Arthritis Rheum 1980; 23: 581-90.
26. LeRoy EC, Medsger TA. Criteria for the classification of early systemic sclerosis. J Rheumatol 2001; 28: 1573-6.
27. Lazaro MA, Maldonado Cocco JA, Catoggio LJ, Babini SM, Messina OD, Garcia Morteo O. Clinical and serologic characteristics of patients with overlap syndrome: Is mixed connective tissue disease a distinct clinical entity? Medicine (Baltimore) 1989; 68: 58-65.
28. Mosca M, Neri R, Bombardieri S. Undifferentiated connective tissue diseases (UCTD): A review of the literature and a proposal for preliminary classification criteria. Clin Exp Rheumatol 1999; 17: 615-20.
29. Mosca M, Tani C, Bombardieri S. Undifferentiated connective tissue diseases (UCTD): A new frontier for rheumatology. Best Prac Res Clin Rheumatol 2007; 21: 1011-23.
30. Lom-Orta H, Alarcon-Segovia D, Diaz-Jouanen E. Systemic lupus erythematosus. Differences between patients who do, and who do not, fulfill classification criteria at the time of diagnosis. Rheumatology 1980; 7: 831-7.
31. Lockshin MD. What is SLE? Editorial. J Rheumatol 1989; 16: 419-20.
32. Asherson RA. New subsets of the antiphospholipid syndrome in 2006: "PRE-APS" (probable APS) and microangiopathic antiphospholipid syndromes ("MAPS"). Autoimmun Rev 2006; 6: 76-80.
33. Rand Mariq H, Valter I. A working classification of scleroderma spectrum disorders: A proposal and the results of testing on a sample of patients. Clin Exp Rheumatol 2004; 22 (Suppl. 33): S5-S13.
34. Martinez JB, Valero JS, Bautista AJ, Restrepo JF, Matteson EL, Rondon F, et al. Erosive arthropathy: Clinical variance in lupus erythematosus and association with anti-CCP case series and review of the literature. Clin Exp Rheumatol 2007; 25: 47-53.
35. Vandergheynst F, Ocmant A, Sordet C, Humbel RL, Goetz J, Roufosse F, et al. Anti-pm/scl antibodies in connective tissue disease: Clinical and biological assessment of 14 patients. Clin Exp Rheumatol 2006; 24: 129-33.
36. Arbuckle MR, McClain MT, Rubertone MV, Scofield RH, Dennis GJ, James JA, et al. Development of autoantibodies before the clinical onset of systemic lupus erythematosus. N Engl J Med 2003; 349: 1526-33.
37. Tani C, Mosca M, d'Ascanio A, Versari D, Virdis A, Ghiadoni L, et al. Chronic inflammation and endothelial dysfunction: Analysis of a cohort of patients with SLE and UCTD. Reumatismo 2006; 58: 212-8.
38. Doria A, Mosca M, Gambari PF, Bombardieri S. Defining unclassifiable connective tissue diseases: Incomplete, undifferentiated or both? J Rheumatol 2005; 32: 213-5.